EU Annex 11 Computerized Systems Alignment
Built-in compliance with Annex 11 clauses: validation lifecycle management, electronic data archiving, regular audit trail reviews, and validated system access control.
Loading…
Computerized systems validation, Qualified Person (QP) batch release, and European data integrity standards
Pharmaceutical manufacturers exporting to the European Union and the United Kingdom must comply with EU GMP Annex 11 and UK MHRA data integrity guidelines. Novaqis delivers a fully validated, high-availability platform engineered for European regulatory expectations and Qualified Person (QP) release workflows.
Product preview
Batch exception review and Qualified Person release workflow
Dashboard / Manufacturing
Dashboard
Recent batches
Technical Architecture
Each capability is built directly into our shared regulatory fabric, eliminating integration glue and validation rework.
Built-in compliance with Annex 11 clauses: validation lifecycle management, electronic data archiving, regular audit trail reviews, and validated system access control.
Accelerate European market release with automated Review-by-Exception dashboards that aggregate deviation records, OOS investigations, and CoA parameters for QP sign-off.
Deploy on dedicated European private cloud instances (AWS/Azure Frankfurt/Dublin) or 100% on-premises plant infrastructure under complete sovereign control.
Meet UK MHRA GxP data integrity standards: complete lifecycle traceability, prevention of contemporaneous data omission, and independent audit trail review tools.
Compliance & control
Audit trails, electronic signatures, role-based access, and deployment choices designed for GxP validation, not bolted on after the fact.
Comprehensive lifecycle documentation, risk-based user requirements (URS), and validated traceability matrices.
System-generated audit records for all GMP-relevant modifications, exportable for regular QA review.
Encrypted automated backups, disaster recovery protocols, and verifiable data restoration testing.
Enterprise Outcomes
Measured operational breakthroughs across quality, manufacturing, and regulatory compliance.
Streamlined QP batch disposition and European market release
Full alignment with EU Annex 11 and UK MHRA inspection standards
Turnkey Computerized System Validation evidence packs
Complete operational visibility across multi-site global manufacturing plants
FAQ